Intellia Therapeutics, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States201-500 Employees
Intellia Therapeutics, Inc. is a biotechnology research company that operates as a clinical-stage biopharmaceutical developer, employing CRISPR gene editing and related core technologies. The company states its mission to develop and potentially commercialize therapies that address severe diseases by durably treating their root causes. It is based in Cambridge, Massachusetts, with the headquarters at 40 Erie Street, Cambridge 02139, and it has a workforce of roughly 201-500 employees. Intellia positions itself as a leading clinical-stage biotechnology firm pursuing a diverse range of therapeutic approaches using its proprietary technologies. Recent news coverage notes activity in in vivo gene-editing programs, including lonvo-z for hereditary angioedema, with an FDA rolling submission initiated.